Bert Vogelstein of Johns Hopkins wondered why there wasn't a blood test to screen for all cancer, not just that of the prostate. Such a test might have detected skin cancer early enough to save his brother. Tumor DNA leaves distinguishing markers, and Dr. Vogelstein researched how to sift for those markers, even in the extremely minute quantities of early-stage cancer.
For the first time, Hopkins researchers say, they are within reach of a general screening tool that could be used to scan broadly—perhaps at an annual physical—for molecular traces of cancer in people with no symptoms.To be sure, significant problems need to be solved:
While the test may detect the presence of cancer DNA in the body, physicians might not know where the tumor is, how dangerous it is, or even whether it is worth treating.The War on Cancer has lasted 43 years so far, and finally it's realistic to believe that it can be won during our children's lifetime, if not our own.
No comments:
Post a Comment